{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:30:45Z","timestamp":1787315445860,"version":"build-2736575974"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011699","name":"BRACE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020276","name":"David Telling Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019415","name":"Elizabeth Blackwell Institute for Health Research, University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","award":["518"],"award-info":[{"award-number":["518"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","award":["518"],"award-info":[{"award-number":["518"]}],"id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W004984\/1, MR\/T018569\/1"],"award-info":[{"award-number":["MR\/W004984\/1, MR\/T018569\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer's Brain Bank UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Depression and dementia are both common diseases. Although new cases of depression are more common in younger adults, there is a second peak at the age of 50\u00a0years suggesting a different pathological process. Late-life depression (LLD) is associated with dementia. However, it remains unclear whether depression represents a dementia prodrome or is a true risk factor for its development.<\/jats:p>\n                    <jats:p>LLD is thought to have a vascular component and this may be a possible link between depression and dementia. We hypothesised that later-life depression is a prodromal manifestation of dementia and would therefore be associated with more AD, and\/or ischaemic brain abnormalities that are present in earlier-life depression or in age- and sex-matched controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We assessed post-mortem orbitofrontal cortex and dorsolateral pre-frontal cortex from 145 individuals in 4 groups: 28 18\u201350-year-olds with depression, 30 older individuals (ages 51\u201390) with depression, 28 with early AD (Braak tangle stages III\u2013IV) and 57 matched controls (17 early-life, 42 later-life). Levels of A\u03b2, phospho-tau and \u03b1-synuclein were assessed by immunohistochemistry and ELISA. To quantify chronic ischaemia, VEGF, MAG and PLP1 were measured by ELISA. To assess pericyte damage, PDGFRB was measured by ELISA. For blood\u2013brain barrier leakiness, JAM-A, claudin 5 and fibrinogen were measured by ELISA. To quantity endothelial activation, the ratio of ICAM1:collagen IV was assessed by immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was no evidence of chronic cerebral hypoperfusion or increased A\u03b2\/tau in either depression group. There was also no indication of pericyte damage, increased blood\u2013brain barrier leakiness or endothelial activation in the OFC or DLPFC in the depression groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Contrary to some previous findings, we have not found evidence of impaired vascular function or increased A\u03b2 in LLD. Our study had a relatively small sample size and limitations in the availability of clinical data. These results suggest that depression is a risk factor for dementia rather than an early manifestation of AD or a consequence of cerebral vascular insufficiency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-023-01299-2","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T03:02:12Z","timestamp":1694487732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Is later-life depression a risk factor for Alzheimer\u2019s disease or a prodromal symptom: a study using post-mortem human brain tissue?"],"prefix":"10.1186","volume":"15","author":[{"given":"Lindsey I.","family":"Sinclair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Edmondson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bone-Connaughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Turecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"issue":"11","key":"1299_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/archpsyc.1997.01830230023003","volume":"54","author":"W Eaton","year":"1997","unstructured":"Eaton W, Anthony J, Gallo J, Cai G, Tien A, Romanoski A, et al. Natural history of diagnostic interview schedule\/ dsm-iv major depression: the Baltimore epidemiologic catchment area follow-up. Arch Gen Psychiatry. 1997;54(11):993\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"1299_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1192\/bjp.bp.111.095950","volume":"200","author":"JM Hegeman","year":"2012","unstructured":"Hegeman JM, Kok RM, van der Mast RC, Giltay EJ. Phenomenology of depression in older compared with younger adults: meta-analysis. Br J Psychiatry. 2012;200(4):275\u201381.","journal-title":"Br J Psychiatry"},{"issue":"11","key":"1299_CR3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"JA Rush","year":"2006","unstructured":"Rush JA, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905\u201317.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1299_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","volume":"11","author":"A Association","year":"2015","unstructured":"Association A. Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dementia. 2015;11(3):332\u201384.","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"1299_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jad.2011.10.023","volume":"140","author":"RSC Lee","year":"2012","unstructured":"Lee RSC, Hermens DF, Porter MA, Redoblado-Hodge MA. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord. 2012;140(2):113\u201324.","journal-title":"J Affect Disord"},{"issue":"7","key":"1299_CR6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1176\/ajp.136.7.895","volume":"136","author":"C Wells","year":"1979","unstructured":"Wells C. Pseudodementia. Am J Psychiatry. 1979;136(7):895\u2013900.","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"1299_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jad.2006.11.004","volume":"101","author":"JA S\u00e1ez-Fonseca","year":"2007","unstructured":"S\u00e1ez-Fonseca JA, Lee L, Walker Z. Long-term outcome of depressive pseudodementia in the elderly. J Affect Disord. 2007;101(1\u20133):123\u20139.","journal-title":"J Affect Disord"},{"key":"1299_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jad.2022.03.043","volume":"306","author":"LI Sinclair","year":"2022","unstructured":"Sinclair LI, Ball HA, Bauermeister S, Gallacher JEJ, Bolea-Alamanac BM. Recurrent depression has persistent effects on cognition but this does not appear to be mediated by neuroinflammation. J Affect Disord. 2022;306:232\u20139.","journal-title":"J Affect Disord"},{"key":"1299_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jad.2023.05.014","volume":"335","author":"LI Sinclair","year":"2023","unstructured":"Sinclair LI, Ball HA, Bolea-Alamanac BM. Does depression in mid-life predispose to greater cognitive decline in later life in the Whitehall II cohort? J Affect Disord. 2023;335:111\u20139.","journal-title":"J Affect Disord"},{"issue":"10","key":"1299_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2215-0366(19)30291-3","volume":"6","author":"M Semkovska","year":"2019","unstructured":"Semkovska M, Quinlivan L, O\u2019Grady T, Johnson R, Collins A, O\u2019Connor J, et al. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):851\u201361.","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"1299_CR11","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.4088\/JCP.09m05349gry","volume":"71","author":"A Singh-Manoux","year":"2010","unstructured":"Singh-Manoux A, Akbaraly TN, Marmot M, Melchior M, Ankri J, Sabia S, et al. Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study. J Clin Psychiatry. 2010;71(10):1379\u201385.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1299_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.31887\/DCNS.2008.10.3\/mabutters","volume":"10","author":"MA Butters","year":"2008","unstructured":"Butters MA, Young JB, Lopez O, Aizenstein HJ, Mulsant BH, Reynolds CF 3rd, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci. 2008;10(3):345\u201357.","journal-title":"Dialogues Clin Neurosci"},{"issue":"11","key":"1299_CR13","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","volume":"161","author":"P Videbech","year":"2004","unstructured":"Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004;161(11):1957\u201366.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1299_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1176\/appi.ajp.161.4.598","volume":"161","author":"S Campbell","year":"2004","unstructured":"Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry. 2004;161(4):598\u2013607.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1299_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000022163","volume":"46","author":"AF Jorm","year":"2000","unstructured":"Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review Gerontology. 2000;46(4):219\u201327.","journal-title":"A review Gerontology"},{"issue":"10113","key":"1299_CR16","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","volume":"390","author":"G Livingston","year":"2017","unstructured":"Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. The Lancet. 2017;390(10113):2673\u2013734.","journal-title":"The Lancet"},{"issue":"6","key":"1299_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/jamapsychiatry.2015.0082","volume":"72","author":"W Katon","year":"2015","unstructured":"Katon W, Pedersen HS, Ribe AR, Fenger-Gr\u00f8n M, Davydow D, Waldorff FB, et al. Impact of depression and diabetes on risk of dementia in a national population-based cohort. JAMA Psychiat. 2015;72(6):612\u20139.","journal-title":"JAMA Psychiat"},{"issue":"4","key":"1299_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jpsychores.2015.01.014","volume":"78","author":"K Zivin","year":"2015","unstructured":"Zivin K, Yosef M, Miller EM, Valenstein M, Duffy S, Kales HC, et al. Associations between depression and all-cause and cause-specific risk of death: a retrospective cohort study in the Veterans health administration. J Psychosom Res. 2015;78(4):324\u201331.","journal-title":"J Psychosom Res"},{"issue":"2","key":"1299_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/JAD-2012-111922","volume":"31","author":"K Steenland","year":"2012","unstructured":"Steenland K, Karnes C, Seals R, Carnevale C, Hermida A, Levey A. Late-life depression as a risk factor for mild cognitive impairment or Alzheimer\u2019s disease in 30 US Alzheimer\u2019s disease centers. J Alzheimer\u2019s Dis. 2012;31(2):265\u201375.","journal-title":"J Alzheimer's Dis"},{"issue":"3","key":"1299_CR20","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.4088\/JCP.15m09989","volume":"77","author":"K Ritchie","year":"2016","unstructured":"Ritchie K, Carriere I, Berr C, Amieva H, Dartigues JF, Ancelin ML, et al. The clinical picture of Alzheimer\u2019s disease in the decade before diagnosis: clinical and biomarker trajectories. J Clin Psychiatry. 2016;77(3):e305\u201311.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"1299_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"RL Ownby","year":"2006","unstructured":"Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"1299_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1192\/bjp.bp.110.078816","volume":"198","author":"C Tsopelas","year":"2011","unstructured":"Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A, et al. Neuropathological correlates of late-life depression in older people. Br J Psychiatry. 2011;198(2):109\u201314.","journal-title":"Br J Psychiatry"},{"issue":"8","key":"1299_CR23","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1212\/01.WNL.0000092914.04345.97","volume":"61","author":"RS Wilson","year":"2003","unstructured":"Wilson RS, Schneider JA, Bienias JL, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003;61(8):1102\u20137.","journal-title":"Neurology"},{"issue":"2","key":"1299_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","volume":"63","author":"MA Rapp","year":"2006","unstructured":"Rapp MA, Schnaider-Beeri M, Grossman HT, et al. Increased hippocampal plaques and tangles in patients with alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry. 2006;63(2):161\u20137.","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"1299_CR25","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/jnnp-2013-307110","volume":"85","author":"A Lebedeva","year":"2014","unstructured":"Lebedeva A, Westman E, Lebedev AV, Li X, Winblad B, Simmons A, et al. Structural brain changes associated with depressive symptoms in the elderly with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2014;85(8):930\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1299_CR26","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/mp.2016.60","volume":"22","author":"L Schmaal","year":"2017","unstructured":"Schmaal L, Hibar DP, S\u00e4mann PG, Hall GB, Baune BT, Jahanshad N, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA major depressive disorder working group. Mol Psychiatry. 2017;22(6):900\u20139. https:\/\/doi.org\/10.1038\/mp.2016.60.","journal-title":"Mol Psychiatry."},{"key":"1299_CR27","doi-asserted-by":"crossref","unstructured":"Yang W, Yu S. Synucleinopathies: common features and hippocampal manifestations. Cell Mol Life Sci.\u00a02017;74(8):1485\u20131501.","DOI":"10.1007\/s00018-016-2411-y"},{"issue":"10","key":"1299_CR28","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archpsyc.1997.01830220033006","volume":"54","author":"GS Alexopoulos","year":"1997","unstructured":"Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. \u201cVascular depression\u201d hypothesis. Arch Gen Psychiatry. 1997;54(10):915\u201322.","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"1299_CR29","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1176\/ajp.153.10.1280","volume":"153","author":"I Lesser","year":"1996","unstructured":"Lesser I, Boone K, Mehringer C, Wohl M, Miller B, Berman N. Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry. 1996;153(10):1280\u20137.","journal-title":"Am J Psychiatry"},{"key":"1299_CR30","first-page":"1","volume":"11","author":"K Barlinn","year":"2015","unstructured":"Barlinn K, Kepplinger J, Puetz V, Illigens BM, Bodechtel U, Siepmann T. Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis. Neuropsychiatr Dis Treat. 2015;11:1\u201314.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"1299_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.biopsych.2012.02.005","volume":"72","author":"M Kivim\u00e4ki","year":"2012","unstructured":"Kivim\u00e4ki M, Shipley MJ, Allan CL, Sexton CE, Jokela M, Virtanen M, et al. Vascular risk status as a predictor of later-life depressive symptoms: a cohort study. Biol Psychiat. 2012;72(4):324\u201330.","journal-title":"Biol Psychiat"},{"key":"1299_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12916-016-0720-5","volume":"14","author":"HJ Aizenstein","year":"2016","unstructured":"Aizenstein HJ, Baskys A, Boldrini M, Butters MA, Diniz BS, Jaiswal MK, et al. Vascular depression consensus report \u2013 a critical update. BMC Med. 2016;14:161.","journal-title":"BMC Med"},{"key":"1299_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuroscience.2013.11.026","volume":"276","author":"IJ Bennett","year":"2014","unstructured":"Bennett IJ, Madden DJ. Disconnected aging: cerebral white matter integrity and age-related differences in cognition. Neuroscience. 2014;276:187\u2013205.","journal-title":"Neuroscience"},{"issue":"16","key":"1299_CR34","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1212\/WNL.0000000000000882","volume":"83","author":"RL Brookes","year":"2014","unstructured":"Brookes RL, Herbert V, Lawrence AJ, Morris RG, Markus HS. Depression in small-vessel disease relates to white matter ultrastructural damage, not disability. Neurology. 2014;83(16):1417\u201323.","journal-title":"Neurology"},{"issue":"7903","key":"1299_CR35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","volume":"603","author":"AC Yang","year":"2022","unstructured":"Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, et al. A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk. Nature. 2022;603(7903):885\u201392.","journal-title":"Nature"},{"key":"1299_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","volume":"131","author":"S Love","year":"2016","unstructured":"Love S, Miners JS. Cerebrovascular disease in ageing and Alzheimer\u2019s disease. Acta Neuropathol. 2016;131:645\u201358.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1299_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"1299_CR38","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1176\/appi.ajp.2021.21010088","volume":"178","author":"P Zhukovsky","year":"2021","unstructured":"Zhukovsky P, Anderson JAE, Coughlan G, Mulsant BH, Cipriani A, Voineskos AN. Coordinate-based network mapping of brain structure in major depressive disorder in younger and older adults: a systematic review and meta-analysis. Am J Psychiatry. 2021;178(12):1119\u201328.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1299_CR39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2174\/1570159X1304150831121909","volume":"13","author":"N Dusi","year":"2015","unstructured":"Dusi N, Barlati S, Vita A, Brambilla P. Brain structural effects of antidepressant treatment in major depression. Curr Neuropharmacol. 2015;13(4):458\u201365.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1299_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2011.05.003","volume":"22","author":"D Arnone","year":"2012","unstructured":"Arnone D, McIntosh AM, Ebmeier KP, Munaf\u00f2 MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol. 2012;22(1):1\u201316.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"1299_CR41","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1093\/brain\/awt146","volume":"136","author":"J Sepulcre","year":"2013","unstructured":"Sepulcre J, Sabuncu MR, Becker A, Sperling R, Johnson KA. In vivo characterization of the early states of the amyloid-beta network. Brain. 2013;136(7):2239\u201352.","journal-title":"Brain"},{"issue":"5","key":"1299_CR42","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neubiorev.2009.01.004","volume":"33","author":"J Savitz","year":"2009","unstructured":"Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev. 2009;33(5):699\u2013771.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"1299_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.biopsych.2006.09.018","volume":"62","author":"CH Chen","year":"2007","unstructured":"Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E, et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry. 2007;62(5):407\u201314.","journal-title":"Biol Psychiatry"},{"key":"1299_CR44","doi-asserted-by":"publisher","first-page":"h5746","DOI":"10.1136\/bmj.h5746","volume":"351","author":"G Sarri","year":"2015","unstructured":"Sarri G, Davies M, Lumsden MA. Diagnosis and management of menopause: summary of NICE guidance. BMJ. 2015;351:h5746.","journal-title":"BMJ"},{"issue":"1","key":"1299_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-019-0519-7","volume":"11","author":"LI Sinclair","year":"2019","unstructured":"Sinclair LI, Kumar A, Darreh-Shori T, Love S. Visual hallucinations in Alzheimer\u2019s disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas. Alzheimer\u2019s Res Ther. 2019;11(1):80.","journal-title":"Alzheimer's Res Ther"},{"issue":"7","key":"1299_CR46","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/jcbfm.2013.46","volume":"33","author":"R Barker","year":"2013","unstructured":"Barker R, Wellington D, Esiri MM, Love S. Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. J Cereb Blood Flow Metab. 2013;33(7):1050\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"1299_CR47","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/bpa.12130","volume":"24","author":"S Miners","year":"2014","unstructured":"Miners S, Moulding H, de Silva R, Love S. Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies. Brain Pathol. 2014;24(4):334\u201343.","journal-title":"Brain Pathol"},{"key":"1299_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2010.09.017","volume":"1363","author":"EL Ashby","year":"2010","unstructured":"Ashby EL, Kehoe PG, Love S. Kallikrein-related peptidase 6 in Alzheimer\u2019s disease and vascular dementia. Brain Res. 2010;1363:1\u201310.","journal-title":"Brain Res"},{"issue":"4","key":"1299_CR49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1750-3639.2010.00374.x","volume":"20","author":"Z van Helmond","year":"2010","unstructured":"van Helmond Z, Miners JS, Kehoe PG, Love S. Higher soluble amyloid beta concentration in frontal cortex of young adults than in normal elderly or Alzheimer\u2019s disease. Brain Pathol. 2010;20(4):787\u201393.","journal-title":"Brain Pathol"},{"issue":"4","key":"1299_CR50","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3233\/JAD-150831","volume":"50","author":"EL Ashby","year":"2016","unstructured":"Ashby EL, Miners JS, Kehoe PG, Love S. Effects of hypertension and anti-hypertensive treatment on amyloid-\u03b2 (A\u03b2) plaque load and A\u03b2-synthesizing and A\u03b2-degrading enzymes in frontal cortex. J Alzheimers Dis. 2016;50(4):1191\u2013203.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1299_CR51","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/archgenpsychiatry.2011.122","volume":"68","author":"A Kumar","year":"2011","unstructured":"Kumar A, Kepe V, Barrio JR, Siddarth P, Manoukian V, Elderkin-Thompson V, et al. Protein binding in patients with late-life depression. Arch Gen Psychiatry. 2011;68(11):1143\u201350.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"1299_CR52","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/2047487318764158","volume":"25","author":"Y Wu","year":"2018","unstructured":"Wu Y, Sun D, Wang B, Li Y, Ma Y. The relationship of depressive symptoms and functional and structural markers of subclinical atherosclerosis: a systematic review and meta-analysis. Eur J Prev Cardiol. 2018;25(7):706\u201316.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"1299_CR53","doi-asserted-by":"publisher","first-page":"20375","DOI":"10.1038\/s41598-021-99794-9","volume":"11","author":"N Siafarikas","year":"2021","unstructured":"Siafarikas N, Kirsebom B-E, Srivastava DP, Eriksson CM, Auning E, Hessen E, et al. Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression. Sci Rep. 2021;11(1):20375.","journal-title":"Sci Rep"},{"issue":"6","key":"1299_CR54","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1176\/appi.ajp.2017.17040442","volume":"175","author":"NJ Donovan","year":"2018","unstructured":"Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, et al. Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. Am J Psychiatry. 2018;175(6):530\u20137.","journal-title":"Am J Psychiatry"},{"key":"1299_CR55","doi-asserted-by":"crossref","unstructured":"Almdahl IS, Agartz I, Hugdahl K, Korsnes MS, for the Alzheimer\u2019s Disease Neuroimaging I. Brain pathology and cognitive scores prior to onset of late-life depression. Int J Geriatr Psychiatry. 2022;37(3):702\u20139.","DOI":"10.1002\/gps.5686"},{"issue":"8","key":"1299_CR56","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1212\/WNL.0000000000000715","volume":"83","author":"RS Wilson","year":"2014","unstructured":"Wilson RS, Capuano AW, Boyle PA, Hoganson GM, Hizel LP, Shah RC, et al. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 2014;83(8):702\u20139.","journal-title":"Neurology"},{"issue":"12","key":"1299_CR57","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/gps.4435","volume":"31","author":"ST McCutcheon","year":"2016","unstructured":"McCutcheon ST, Han D, Troncoso J, Koliatsos VE, Albert M, Lyketsos CG, et al. Clinicopathological correlates of depression in early Alzheimer\u2019s disease in the NACC. Int J Geriatr Psychiatry. 2016;31(12):1301\u201311.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1299_CR58","doi-asserted-by":"publisher","first-page":"111443","DOI":"10.1016\/j.pscychresns.2022.111443","volume":"320","author":"L Emsell","year":"2022","unstructured":"Emsell L, Vanhaute H, Vansteelandt K, De Winter F-L, Christiaens D, Van den Stock J, et al. An optimized MRI and PET based clinical protocol for improving the differential diagnosis of geriatric depression and Alzheimer\u2019s disease. Psychiatry Res Neuroimaging. 2022;320:111443.","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"3","key":"1299_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1176\/appi.ajp.2016.16030319","volume":"174","author":"FL De Winter","year":"2017","unstructured":"De Winter FL, Emsell L, Bouckaert F, Claes L, Jain S, Farrar G, et al. No association of lower hippocampal volume with Alzheimer\u2019s disease pathology in late-life depression. Am J Psychiatry. 2017;174(3):237\u201345.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1299_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biopsych.2022.01.012","volume":"92","author":"M Johansson","year":"2022","unstructured":"Johansson M, Stomrud E, Johansson PM, Svenningsson A, Palmqvist S, Janelidze S, et al. Development of apathy, anxiety, and depression in cognitively unimpaired older adults: effects of Alzheimer\u2019s disease pathology and cognitive decline. Biol Psychiatry. 2022;92(1):34\u201343.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"1299_CR61","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.biopsych.2020.06.017","volume":"89","author":"RS Mackin","year":"2021","unstructured":"Mackin RS, Insel PS, Landau S, Bickford D, Morin R, Rhodes E, et al. Late-life depression is associated with reduced cortical amyloid burden: findings from the Alzheimer\u2019s disease neuroimaging initiative depression project. Biol Psychiatry. 2021;89(8):757\u201365.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"1299_CR62","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/mp.2013.20","volume":"18","author":"WD Taylor","year":"2013","unstructured":"Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18(9):963\u201374.","journal-title":"Mol Psychiatry"},{"key":"1299_CR63","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.neubiorev.2018.04.003","volume":"90","author":"SP Rensma","year":"2018","unstructured":"Rensma SP, van Sloten TT, Launer LJ, Stehouwer CDA. Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2018;90:164\u201373.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1299_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/jnnp.70.1.83","volume":"70","author":"AJ Thomas","year":"2001","unstructured":"Thomas AJ, Ferrier IN, Kalaria RN, Perry RH, Brown A, O\u2019Brien JT. A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry. 2001;70(1):83\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1299_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-2990.2010.01101.x","volume":"36","author":"M Santos","year":"2010","unstructured":"Santos M, Gold G, K\u00f6vari E, Herrmann FR, Hof PR, Bouras C, et al. Neuropathological analysis of lacunes and microvascular lesions in late-onset depression. Neuropathol Appl Neurobiol. 2010;36(7):661\u201372.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"1299_CR66","first-page":"161","volume":"54","author":"F G\u00f6the","year":"2012","unstructured":"G\u00f6the F, Enache D, Wahlund LO, Winblad B, Crisby M, L\u00f6kk J, et al. Cerebrovascular diseases and depression: epidemiology, mechanisms and treatment. Panminerva Med. 2012;54(3):161\u201370.","journal-title":"Panminerva Med"},{"issue":"3","key":"1299_CR67","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ecl.2013.05.002","volume":"42","author":"F Pouwer","year":"2013","unstructured":"Pouwer F, Nefs G, Nouwen A. Adverse effects of depression on glycemic control and health outcomes in people with diabetes: a review. Endocrinol Metab Clin North Am. 2013;42(3):529\u201344.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"1299_CR68","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.genhosppsych.2009.04.002","volume":"31","author":"B Roshanaei-Moghaddam","year":"2009","unstructured":"Roshanaei-Moghaddam B, Katon WJ, Russo J. The longitudinal effects of depression on physical activity. Gen Hosp Psychiatry. 2009;31(4):306\u201315.","journal-title":"Gen Hosp Psychiatry"},{"key":"1299_CR69","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2021.09.025","volume":"111","author":"L Gerritsen","year":"2022","unstructured":"Gerritsen L, Sigurdsson S, Jonsson PV, Gudnason V, Launer LJ, Geerlings MI. Depressive symptom profiles predict dementia onset and brain pathology in older persons. The AGES-Reykjavik study. Neurobiol Aging. 2022;111:14\u201323.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1299_CR70","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3233\/JAD-215241","volume":"85","author":"L Gerritsen","year":"2022","unstructured":"Gerritsen L, Twait EL, Jonsson PV, Gudnason V, Launer LJ, Geerlings MI. Depression and dementia: the role of cortisol and vascular brain lesions. AGES-Reykjavik Study. J Alzheimers Dis. 2022;85(4):1677\u201387.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"1299_CR71","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.jagp.2013.10.005","volume":"22","author":"JW Kirton","year":"2014","unstructured":"Kirton JW, Resnick SM, Davatzikos C, Kraut MA, Dotson VM. Depressive symptoms, symptom dimensions, and white matter lesion volume in older adults: a longitudinal study. Am J Geriatr Psychiatry. 2014;22(12):1469\u201377.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"1299_CR72","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/gps.3911","volume":"28","author":"JJ Miguel-Hidalgo","year":"2013","unstructured":"Miguel-Hidalgo JJ, Jiang W, Konick L, Overholser JC, Jurjus GJ, Stockmeier CA, et al. Morphometric analysis of vascular pathology in the orbitofrontal cortex of older subjects with major depression. Int J Geriatr Psychiatry. 2013;28(9):959\u201370.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1\u20133","key":"1299_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.schres.2009.04.019","volume":"112","author":"K Barley","year":"2009","unstructured":"Barley K, Dracheva S, Byne W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr Res. 2009;112(1\u20133):54\u201364.","journal-title":"Schizophr Res"},{"issue":"3","key":"1299_CR74","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.mp.4001565","volume":"10","author":"C Aston","year":"2005","unstructured":"Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry. 2005;10(3):309\u201322.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"1299_CR75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","volume":"202","author":"BS Diniz","year":"2013","unstructured":"Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer\u2019s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329\u201335.","journal-title":"Br J Psychiatry"},{"issue":"7","key":"1299_CR76","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jamapsychiatry.2017.0984","volume":"74","author":"MJM van Agtmaal","year":"2017","unstructured":"van Agtmaal MJM, Houben A, Pouwer F, Stehouwer CDA, Schram MT. Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis. JAMA Psychiat. 2017;74(7):729\u201339.","journal-title":"JAMA Psychiat"},{"issue":"10","key":"1299_CR77","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.euroneuro.2015.06.001","volume":"25","author":"P-T Tseng","year":"2015","unstructured":"Tseng P-T, Cheng Y-S, Chen Y-W, Wu C-K, Lin P-Y. Increased levels of vascular endothelial growth factor in patients with major depressive disorder: a meta-analysis. Eur Neuropsychopharmacol. 2015;25(10):1622\u201330.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1299_CR78","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1742-2094-10-142","volume":"10","author":"S Najjar","year":"2013","unstructured":"Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D. Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation. 2013;10:142.","journal-title":"J Neuroinflammation"},{"key":"1299_CR79","doi-asserted-by":"crossref","unstructured":"Kealy J, Greene C, Campbell M. Blood-brain barrier regulation in psychiatric disorders. Neuroscience Letters. 2020;726:133664","DOI":"10.1016\/j.neulet.2018.06.033"},{"issue":"9","key":"1299_CR80","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1038\/s41380-022-01618-3","volume":"27","author":"H Matsuno","year":"2022","unstructured":"Matsuno H, Tsuchimine S, O\u2019Hashi K, Sakai K, Hattori K, Hidese S, et al. Association between vascular endothelial growth factor-mediated blood-brain barrier dysfunction and stress-induced depression. Mol Psychiatry. 2022;27(9):3822\u201332.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"1299_CR81","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","volume":"20","author":"C Menard","year":"2017","unstructured":"Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20(12):1752\u201360.","journal-title":"Nat Neurosci"},{"issue":"6","key":"1299_CR82","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1073\/pnas.1914655117","volume":"117","author":"KA Dudek","year":"2020","unstructured":"Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, et al. Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression. Proc Natl Acad Sci U S A. 2020;117(6):3326\u201336.","journal-title":"Proc Natl Acad Sci U S A"}],"updated-by":[{"DOI":"10.1186\/s13195-024-01404-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000}}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01299-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-023-01299-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01299-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:14:00Z","timestamp":1708064040000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-023-01299-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1186\/s13195-023-01299-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"18 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13195-024-01404-z","URL":"https:\/\/doi.org\/10.1186\/s13195-024-01404-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this work was provided by the Greater Manchester East NRES committee (ref 17\/NW\/0126). All tissue collected by both the South West Dementia Brain Bank and the Douglas Bell Canada Brain Bank is donated with consent from the individual\u2019s next of kin. Consent is given at the time of donation for the tissue to be used in research studies which have obtained ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This work was funded by BRACE Alzheimer\u2019s Research and the David Telling Charitable Trust.\u00a0 The South West Dementia Brain Bank is funded by BRACE, the Alzheimer\u2019s Society & Alzheimer\u2019s Research UK as part of Brains for Dementia Research.\u00a0 The Douglas Bell Brain Bank is funded by the fonds du recherche du Quebec-Sant\u00e9 through the R\u00e9seau qu\u00e9b\u00e9cois sur le suicide, les troubles de l\u2019humeur et les troubles associ\u00e9s, as well as Brain Canada Foundation.Sinclair has received funding from the Alzheimer\u2019s Society (grant 518), the Elizabeth-Blackwell institute for Health Research University of Bristol and the Wellcome Trust Institutional Strategic Support Fund (204813\/Z\/16\/Z), BRACE, the David Telling Charitable Trust and a travel grant from the Gatsby Foundation\/Royal College of Psychiatrists. Love is in receipt of funding from the Medical Research Council (MR\/W004984\/1, MR\/T018569\/1), UK Dementia Research Institute, and Alzheimer's Brain Bank UK. Morisaki is funded by the Alzheimer\u2019s Society (grant 518). GT, SC, ME, AM and AB-C have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}